Search

Certara Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

8.49 0.95

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.25

Max

8.44

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-380K

-9.1M

Pardavimai

-14M

93M

P/E

Sektoriaus vid.

100.714

56.432

Pelnas, tenkantis vienai akcijai

0.05

Pelno marža

-9.803

Darbuotojai

1,515

EBITDA

-4.2M

12M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

-3.8% downside

Dividendai

By Acuity

Kitas uždarbis

2026-11-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-52M

1.2B

Ankstesnė atidarymo kaina

7.54

Ankstesnė uždarymo kaina

8.49

Naujienos nuotaikos

By Acuity

50%

50%

106 / 339 reitingas Healthcare

Certara Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-18 20:07; UTC

Certara Inc's stock is declining, having pulled back from an earlier peak, and remains lower compared to Thursday's close while trading above its 20-day moving average.

2026-09-17 23:31; UTC

Certara Inc is rising in after-market trading, reaching a peak shortly after the market closed, significantly above its 20-day moving average.

2026-09-16 22:01; UTC

Certara Inc is seeing a slight uptick in after-market trading, recovering from a brief dip to achieve a modest gain within its one-month trading range.

2026-09-15 20:01; UTC

Certara Inc shares are higher during Tuesday's session, diverging from broader market sentiment impacted by a decline in the NY Empire State Manufacturing Index.

2026-09-14 19:51; UTC

Certara Inc shares are trading higher, continuing a recent upward trend. No specific news was identified to explain this price movement.

2026-09-10 20:07; UTC

Shares of Certara Inc. are trading lower today, reflecting broader market trends amid five consecutive sessions of declines and pressure from recent interest rate hikes.

2026-09-09 20:07; UTC

Certara Inc. shares are lower today, breaking the upward trend seen since Tuesday's close. No specific news or development was identified.

2026-09-08 19:41; UTC

Certara Inc is lower today, impacted by weakness in the Health Care Technology sub-sector. The stock remains below its 20-day moving average.

2026-09-03 20:07; UTC

Certara Inc shares are lower today, continuing a decline since Wednesday amid a broader downturn in the health care technology sector.

2026-09-01 20:08; UTC

Certara Inc shares are lower today, continuing a downward trend from earlier sessions and remaining below the 20-day moving average.

2026-08-31 22:02; UTC

Shares of Certara Inc. are trading lower during after-market hours, reversing a trend of higher daily closes. No specific news was identified.

2026-08-27 20:01; UTC

Certara Inc shares are higher today, continuing an upward trend since Wednesday. Broader market sentiment may be influenced by declining initial jobless claims.

2026-08-26 19:56; UTC

Shares of Certara Inc. are modestly higher today, reflecting typical intraday fluctuations. No specific company news was identified to explain the move.

2026-08-25 20:51; UTC

Certara Inc shares are higher in after-market trading, continuing a rise since Tuesday's close amid favorable market conditions and lower U.S. Treasury yields.

2026-08-24 20:01; UTC

Certara Inc shares are lower today, continuing a decline since Friday's close amid broader market pressures and geopolitical concerns affecting oil supply and inflation.

2026-08-21 19:56; UTC

Certara Inc shares are lower today, continuing a decline since Thursday. The stock is significantly below its 20-day moving average.

2026-08-20 20:06; UTC

Certara Inc shares are higher during Thursday's session, reflecting broader market dynamics and notable increases in U.S. Treasury yields and crude oil prices.

2026-08-19 23:56; UTC

Certara Inc. shares are lower in after-hours trading, showing slight declines since Wednesday's close while remaining above the 20-day moving average.

2026-08-18 19:36; UTC

Certara Inc. is trading higher during Tuesday's session, maintaining routine performance within a narrow range above its 20-day moving average.

2026-08-13 19:41; UTC

Certara Inc is rising, supported by strength in the Health Care Technology sub-sector, despite a slight pullback from earlier session highs.

2026-08-12 19:46; UTC

News

Certara shares are lower as Jefferies raises the price target to $7.45 from $6.00 while maintaining a Hold rating.

2026-08-11 23:51; UTC

Certara Inc is higher in after-hours trading, reflecting strong momentum and robust interest following notable activity earlier in the session.

2026-08-07 19:26; UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

2026-08-06 20:02; UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

2026-08-05 20:13; UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

2026-08-04 20:03; UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

2026-08-03 19:26; UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

2026-07-31 19:26; UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

2026-07-30 19:58; UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

2026-07-29 18:53; UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

Akcijų palyginimas

Kainos pokytis

Certara Inc Prognozė

Kainos tikslas

By TipRanks

-3.8% į apačią

12 mėnesių prognozė

Vidutinis 8.1 USD  -3.8%

Aukščiausias 9 USD

Žemiausias 7 USD

Remiantis 7 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Certara Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

7 ratings

1

Pirkti

6

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

106 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.